PROFFERED PAPERS
Monday, March 26   —  8:00 AM   —  CC 6 C/F


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...

...then notice the 'Event Added' prompt
in the toolbar above as feedback:
 



Section B - HEMATOPATHOLOGY
Chaired by: Amy Chadburn and Judith Ferry



TimeTitle and AuthorsItinerary
Planner
8:00 MALT Lymphoma: Novel Translocations and Three Distinct Gene Expression Profiles (1196)
B Streubel, M Bilban, M Raderer, A Chott, Medical University of Vienna, Vienna, Austria
Add
8:15 CPG Oligonucleotides Induce Growth of Malt Lymphoma Cells In Vitro And Reveal Novel Cytogenetic Abnormalities (1180)
ED Remstein, ME Law, GW Dewald, PJ Kurtin, A Dogan, Mayo Clinic, Rochester, MN
Add
8:30 Array-Based Comparative Genomic Hybridization of Splenic and Nodal Marginal Zone Lymphomas (1201)
F Vega, PA Lennon, M Luthra, D Jones, M Breeden, JH Cho, LJ Medeiros, R Luthra The University of Texas MD Anderson Cancer Center, Houston, TX
Add
8:45 The Diversity of p53/p21 Transactivation Phenotype of p53 Signaling Pathway and Their Relationship to TP53 Gene Mutation and Clinical Outcome in Diffuse Large B-Cell Lymphoma (1217)
KH Young, MB Möller, GWB Colleoni, M Sánchez-Beato, FR Kerbauy, K Leroy, MA Piris, JC Eickhoff, K Kanehira, S Cook, EA Ranheim, BS Kahl, M Olivier, E Campo, J Delabie, RD Gascoyne, A Rosenwald, RM Braziel, ES Jaffe, WH Wilson, LM Staudt, WC Chan, DD Weisenburger, TC Greiner, University of Wisconsin School of Medicine and Public Health, Madison, WI; Odense University Hospital, Odense, Denmark; Federal University of São Paulo, Brazil; Spanish National Cancer Center, Madrid, Spain; Hospital Henri Mondor, Paris, France; World Health Organization, Lyon, France; Lymphoma Leukemia Molecular Profiling Project
Add
9:00 The Frequency of Specific Chromosomal Abnormalities in Primary Central Nervous System Lymphoma Differs from Systemic Diffuse Large B-Cell Lymphoma , Suggesting a Distinct Pathogenesis (1077)
FM Cady, ME Law, AB Porter-Umphrey, BP O'Neill, C Giannini, ED Remstein, A Dogan, Mayo Clinic, Rochester, MN
Add
9:15 Analysis of the VH Mutational Status in Mantle Cell Lymphoma — A Comparative Study Evaluating Methods Differing in the Choice of PCR Templates and the Use of Subcloning (1146)
S Lefresne, E Strachan, A Battochio, R Lai, Cross Cancer Institute, Edmonton, AB, Canada
Add
9:30 RECESS, EXHIBITS, POSTER SESSION I  
11:00 T(14;18)-Negative Non-Cutaneous Follicular Lymphoma : A Clinicopathological Study of 59 Cases (1193)
XL Shi, BJ Dave, F d'Amore, E Chan, S Jain, W Sanger, WWL Choi, TC Greiner, P Aoun, DD Weisenburger, WC Chan, K Fu University of Nebraska Medical Center, Omaha, NE; Århus University Hospital, Århus, Denmark
Add
11:15 Loss of Carp-1 Expression Is a Poor Prognostic Factor in Follicular Lymphomas (1065)
MS Almiski, N Razumilava, M Kurrer, A Rishi, E Levi, Wayne State University, Detroit, MI; University Hospital, Zurich, Switzerland; John D. Dingell VAMC, Detroit, MI
Add
11:30 Follicular Lymphoma: Protein-Based Survival (PBS) Predictor Using Tissue-Microarrays (1078)
FI Camacho, R Arranz-Saez, C Corbacho, J Cannata, L Cereceda, L Gonzalez, ME Perez-Martin, T Alvaro, L Sanchez-Verde, C Montalban, JF Garcia, C Bellas, MA Piris Hospital Virgen de la Salud, Toledo, Spain; Hospital La Princesa, Madrid, Spain; Hospital Puerta Hierro, Madrid, Spain; Spanish National Cancer Centre, Madrid, Spain; Hospital Ramon y Cajal, Madrid, Spain; Hospital 12 de Octubre, Madrid, Spain; Hospital Virgen de la Cinta, Tortosa, Spain
Add
11:45 Clonal Relationship between Follicular Lymphoma and Histiocytic/Dendritic Cell Neoplasms Occurring in the Same Patient (1098)
AL Feldman, DA Arber, M Raffeld, JS Burke, S Pittaluga, R Warnke, ES Jaffe National Cancer Institute, Bethesda, MD; Stanford University, Stanford, CA; Alta Bates Summit Medical Center, Berkeley, CA
Add